This event has run. Thank you to our speakers, sponsors, and delegates who joined us for the 2026 summit.

Radiopharm Doses First Patient in Phase I Prostate Cancer Radiotherapy Study
Alpha‑Emitting PSMA Therapies Gain Momentum Across Radiopharma Leaders
Ratio Therapeutics Highlights the Next Wave of Radiopharmaceutical Manufacturing Standards
Radiopharma Veterans From Novartis‑Built Platforms Strengthen Emerging Biotechs
Radiopharma Takes Center Stage as Global Biopharma Partnering Accelerates

Beyond “Me-Too” Therapies: Prioritizing Targets Beyond PSMA for Meaningful RLT & Indication Differentiation

Beyond “Me-Too” Therapies: Prioritizing Targets Beyond PSMA for Meaningful RLT & Indication Differentiation

10:59 am - Thursday 23rd July 2026

Speakers:

Eric Ahrens

Professor

UC San Diego